Journal article

Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian Diabetes, Obesity and Lifestyle Study

Allan J Wiseman, Brigid M Lynch, Adrian J Cameron, David W Dunstan

Cancer Causes & Control | SPRINGER | Published : 2014

Grants

Awarded by Early Career Fellowships from the National Health and Medical Research Council


Awarded by Future Fellowship from the Australian Research Council


Awarded by National Health and Medical Research Council (NHMRC)


Funding Acknowledgements

Lynch and Cameron are supported by Early Career Fellowships from the National Health and Medical Research Council (586727 and 1013313). Dunstan is supported by a Future Fellowship from the Australian Research Council (FT100100918). Baker IDI Heart and Diabetes Institute receives support from the Victorian Government's Operational Infrastructure Support Program. The AusDiab study, co-coordinated by Baker IDI Heart and Diabetes Institute, gratefully acknowledges the generous support given by National Health and Medical Research Council (NHMRC Grant 233200), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services-Northern Territory, Department of Health and Human Services-Tasmania, Department of Health-New South Wales, Department of Health-Western Australia, Department of Health-South Australia, Department of Human Services-Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian and FH Flack Trust, Menzies Research Institute, Merck Sharp and Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, Sanofi Synthelabo. The AusDiab study was also supported in part by the Victorian Government's OIS Program. We acknowledge the AusDiab project manager Shirley Murray and administrative associate Sue Fournel for the contribution to the study. We also thank the field coordinators Marita Dalton (1999-2000), Theresa Whalen (2004-2005) and Annaliese Bonney (2004-2005), as well as all the AusDiab support staff from 1999/2000 and 2004/2005. We would like to thank the participants for volunteering their time to participate in the AusDiab study.